Jim Simons Savara Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$3.18 - $4.9 $486,540 - $749,700	153,000 Added 147.26%	256,900 $1.21 Million
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.88 $411,048 - $536,992	-138,400 Reduced 57.12%	103,900 $393,000
Q2 2023 Aug 11, 2023	BUY	$1.69 - $3.24 $239,304 - $458,784	141,600 Added 140.62%	242,300 $774,000
Q1 2023 May 12, 2023	BUY	$1.6 - $2.82 $48,960 - $86,292	30,600 Added 43.65%	100,700 $196,000
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.64 $111 - $164	100 Added 0.14%	70,100 $109,000
Q3 2022 Nov 14, 2022	BUY	$1.36 - $1.88 $19,040 - $26,320	14,000 Added 25.0%	70,000 $109,000
Q2 2022 Aug 12, 2022	BUY	$1.1 - $1.58 $43,230 - $62,094	39,300 Added 235.33%	56,000 $85,000
Q1 2022 May 13, 2022	SELL	$1.05 - $1.36 $344,181 - $445,797	-327,792 Reduced 95.15%	16,700 $22,000
Q4 2021 Feb 11, 2022	BUY	$1.04 - $1.34 $34,623 - $44,611	33,292 Added 10.7%	344,492 $427,000
Q3 2021 Nov 12, 2021	BUY	$1.18 - $1.64 $160,304 - $222,795	135,851 Added 77.47%	311,200 $429,000
Q2 2021 Aug 13, 2021	BUY	$1.51 - $2.29 $167,079 - $253,386	110,649 Added 171.02%	175,349 $298,000
Q1 2021 May 13, 2021	SELL	$1.17 - $2.33 $392,184 - $781,016	-335,200 Reduced 83.82%	64,700 $135,000
Q4 2020 Feb 10, 2021	BUY	$1.0 - $1.47 $10,200 - $14,994	10,200 Added 2.62%	399,900 $460,000
Q3 2020 Nov 13, 2020	BUY	$1.09 - $2.21 $424,773 - $861,237	389,700 New	389,700 $425,000
Q1 2020 May 14, 2020	SELL	$1.91 - $4.08 $185,617 - $396,502	-97,182 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.71 - $4.91 $68,999 - $477,163	97,182 New	97,182 $435,000
Q2 2019 Aug 12, 2019	SELL	$2.37 - $11.7 $149,743 - $739,241	-63,183 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$6.71 - $8.6 $423,957 - $543,373	63,183 New	63,183 $466,000

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

Nea Management Company, LLC Timonium, MD

24.5M
Shares

$78.3 Million
7.93% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

14.6M
Shares

$46.6 Million
11.08% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

12.4M
Shares

$39.6 Million
6.8% of portfolio
Wellington Management Group LLP Boston, MA

8.62M
Shares

$27.6 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

8.16M
Shares

$26.1 Million
1.86% of portfolio

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account